Daily non-political popular news in brief.

Gene profiling predicts resistance to breast cancer drug Herceptin

Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.

Read more »

Keywords: gene, profiling, predicts, resistance, breast, cancer, drug, herceptin, predict

« Previous | Next »

Similar news on "Gene profiling predicts resistance to breast cancer drug Herceptin":

1. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
   09-24-2007 · EurekAlert!
   A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14) today (Monday 24 September).
   Similar news · Read more »
   
2. Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
   10-31-2006 · EurekAlert!
   Scientists have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer. They looked at cancer cells from more than 2,000 breast cancer patients and found that this commandeering or "organizing" ability is increasingly lost in cancer cells and associated with the progression of disease. The more the gene is expressed in breast cancer, the better the patient did.
   Similar news · Read more »
   
3. Other highlights in the Nov. 13 JNCI
   11-13-2007 · EurekAlert!
   Other highlights in the Nov. 13 JNCI include a simple model to predict breast cancer risk, the link between smoking and rectal cancer, research into how a cancer drug causes heart damage, a gene that may inhibit lung cancer, BRCA1's influence on drug response, and the difficulties assigning patients to cancer subtypes.
   Similar news · Read more »
   
4. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
   09-25-2007 · EurekAlert!
   Researchers have found that the breast cancer susceptibility gene, BRCA1, plays a significant role in nonsmall cell lung cancer. They told the European Cancer Conference in Barcelona that not only can it be used to predict outcome for patients with NSCLC, but it may also prove to be a valuable tool in choosing the best therapy for them.
   Similar news · Read more »
   
5. New biomarker predicts effectiveness of breast cancer drugs
   12-07-2006 · EurekAlert!
   University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
   Similar news · Read more »
   
6. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
7. Guardian of genome predicts treatment outcomes for childhood cancer
   11-04-2007 · EurekAlert!
   Researchers have identified a new role for a cancer-prevention gene in the response to drug treatment for childhood cancer.
   Similar news · Read more »
   
8. Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
   10-11-2007 · EurekAlert!
   A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 -- which normally applies the brakes on a cancer-causing gene -- is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.
   Similar news · Read more »
   
9. Cell response to stress signals predicts tumors in women with common pre-breast cancer
   11-12-2007 · EurekAlert!
   A specific biological response to cellular stress may predict the likelihood of future tumor formation of the most common, noninvasive form of pre-malignant breast cancer -- ductal carcinoma in situ, or DCIS.
   Similar news · Read more »
   
10. 10 Top Australian Scientists Predict Major Medical Advances
    10-10-2006 · ScienceDaily
    Australians will soon be able to find out how good their genes are at fighting disease, what risks they are susceptible to and what they can do to prevent ill-health. And by the turn of the century it will be commonplace to have a bad combination of genes repaired to avoid disease. A new report compiled by Research Australia with 10 top Australian medical researchers predicts individual gene profiling will revolutionize health care within a decade.
    Similar news · Read more »